> top > docs > PMC:7258756 > spans > 32917-33541 > annotations

PMC:7258756 / 32917-33541 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
480 15-25 Species denotes SARS-CoV-2 Tax:2697049
481 613-623 Species denotes SARS-CoV-2 Tax:2697049

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T228 74-76 Body_part denotes nt http://purl.org/sig/ont/fma/fma82740

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T175 15-23 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T176 15-19 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T177 613-621 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T178 613-617 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T263 202-203 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T264 223-225 http://purl.obolibrary.org/obo/CLO_0001407 denotes 52
T265 445-447 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T137 74-76 Chemical denotes nt http://purl.obolibrary.org/obo/CHEBI_36976

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T220 0-201 Sentence denotes The two Indian SARS-CoV-2 sequences were found to be non-identical (0.04% nt divergence), and the result of phylogenetic analysis indicated that there were two different introductions into the country.
T221 202-413 Sentence denotes A recent study using 52 published GenBank sequences showed evidence of substantial genetic heterogeneity and estimated the time to the most recent common ancestor to be December 5, 2019 (95% confidence interval:
T222 414-448 Sentence denotes November 6 - December 13, 2019)22.
T223 449-624 Sentence denotes Continuous monitoring and analysis of the sequences from the affected countries would be vital to understand the genetic evolution and rates of substitution of the SARS-CoV-2.